U.S. Markets open in 9 hrs
  • S&P Futures

    4,534.00
    +25.50 (+0.57%)
     
  • Dow Futures

    34,203.00
    +201.00 (+0.59%)
     
  • Nasdaq Futures

    15,945.75
    +76.00 (+0.48%)
     
  • Russell 2000 Futures

    2,165.70
    +19.40 (+0.90%)
     
  • Crude Oil

    65.97
    +0.40 (+0.61%)
     
  • Gold

    1,777.80
    -6.50 (-0.36%)
     
  • Silver

    22.37
    +0.03 (+0.14%)
     
  • EUR/USD

    1.1321
    -0.0001 (-0.0113%)
     
  • 10-Yr Bond

    1.4340
    -1.4430 (-100.00%)
     
  • Vix

    31.12
    -27.19 (-100.00%)
     
  • GBP/USD

    1.3288
    +0.0011 (+0.0797%)
     
  • USD/JPY

    113.0610
    +0.2810 (+0.2492%)
     
  • BTC-USD

    56,949.03
    +30.74 (+0.05%)
     
  • CMC Crypto 200

    1,443.93
    -25.15 (-1.71%)
     
  • FTSE 100

    7,168.68
    +109.23 (+1.55%)
     
  • Nikkei 225

    27,832.49
    -103.13 (-0.37%)
     

Is Bristol Myers Squibb Stock a Buy?

·5 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Bristol Myers Squibb (NYSE: BMY) stock hasn't performed very well so far this year. In this Motley Fool Live video recorded on Sept. 15, Motley Fool contributors Keith Speights and Brian Orelli answer a viewer's question about whether or not the big pharma stock is a buy.